Search Results
Viewing: 671-680 of 3170 | All
Article
Strollers
Although strollers are typically used to safely transport children, on average, one child aged 5 years and younger is treated in U.S. hospitals every 45 minutes for a stroller- related injury.
Article
Oral-GI Microbiology Research Affinity Group
The Oral and GI Microbiology Research Affinity Group (OGM RAG) at Nationwide Children’s Hospital will bring together like minded clinicians and basic scientists that are actively involved in research in oral and gastrointestinal microbiology as it affects human disease.
Article
Breuer Lab
The focus of the Breuer and Shinoka Labs is to design a tissue engineered vascular graft (TEVG) that can be used during surgery that, over time transitions to a normal blood vessel that will grow with our pediatric patients.
Article
Featured News
Stay up to date on the latest news releases coming out of the Center for Pediatric Trauma Research.
News
Elaine R. Mardis, PhD, Named American Association for Cancer Research President-Elect 2018-2019
The members of the American Association for Cancer Research (AACR) have elected Nationwide Children's Hospital's Elaine R. Mardis, PhD, as their President-Elect for 2018-2019.
News
Injuries to High School Baseball Players Becoming More Serious
Although the overall rate of high school baseball-related injuries has decreased within the last 10 years, the severity of injuries that occur has increased, according to a new study conducted by researchers at the Center for Injury Research and Policy (CIRP) of The Research Institute at Nationwide
Article
Our Innovation
Growing our own Cardiac Vessels Most doctors use plastic grafts to replace damaged arteries and blood vessels in children’s hearts. The problem is that organic hearts grow over time and synthetic plastics do not. To solve this, Dr. Christopher Breuer and Dr.
Article
ALCHEMIST
The Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trials, or ALCHEMIST, is a group of clinical trials for patients with certain types of early-stage non-small cell lung cancers (NSCLC) that have been treated surgically.
News
Nationwide Childrens Hospital Researchers Receive Cystic Fibrosis Foundation Grant to Study Cell Therapy
A team of physician-scientists led by Susan D. Reynolds, PhD, at Nationwide Children’s Hospital recently received a grant from the Cystic Fibrosis Foundation to study the safety and effectiveness of cell therapy for the treatment of cystic fibrosis.
Article
Flanigan Lab
Under the direction of Kevin Flanigan, MD, the Flanigan Lab focuses on the genetic and molecular characterization of inherited neuromuscular diseases, and toward the development of therapies directed toward these diseases.